DEVA:IST
Deva Holding AS
TRYÂ 92.45
arrow_upward
+2.10%(+1.90) 1D
Sep 4, 6:10:00 PM GMT+3 · TRY
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DEVA...
Open
TRYÂ 90.60
High
TRYÂ 93.00
Low
TRYÂ 90.60
Mkt. cap
18.49B
Avg. vol.
803.48K
Volume
492.66K
52-wk high
TRYÂ 95.85
52-wk low
TRYÂ 57.50
EPS
-TRYÂ 4.21
Shares outstanding
200.02M
No. of employees
3K
Open
TRYÂ 90.60
High
TRYÂ 93.00
Low
TRYÂ 90.60
Mkt. cap
18.49B
Avg. vol.
803.48K
Volume
492.66K
52-wk high
TRYÂ 95.85
52-wk low
TRYÂ 57.50
EPS
-TRYÂ 4.21
Shares outstanding
200.02M
No. of employees
3K
Profile
DEVA Holding A.Åž. is a Turkish pharmaceutical company operating since 1958. Its principal activities include the development, manufacture and marketing of human pharmaceuticals and active pharmaceutical ingredients. The company also operates in veterinary medicines, cologne, medical ampoules and food supplements.
A majority stake in the company was acquired by EastPharma in 2006. DEVA Holding is listed on Borsa Istanbul, and its chairman and chief executive officer is Philipp Haas.
As of 2025, the company had more than 675 products across 15 therapeutic areas. According to IQVIA data cited in its annual report, DEVA ranked third in the Turkish pharmaceutical market by unit sales in 2025, with a market share of 4.5%. Wikipedia
About Deva Holding AS